Fox Business - The Power to Prosper
Search Site

Abbott Laboratories

How to invest amid volatility

JPMorgan Global Market Strategist David Lebovitz, Holland & Company Chairman Mike Holland and Stifel Nicolaus Portfolio Manager Chad Morganlander discuss how to invest in an unstable market environment.

Read More

  1. What’s driving market action?

    Glenmede Director of Investment Strategy Jason Pride and Teddy Weisberg of Seaport Securities discuss the state of the markets and where to invest.

  2. Despite volatility, Trinity Industries a way to gain from rail industry?

    FBN’s Charles Payne, Stifel Nicolaus Portfolio Manager Chad Morganlander and Penn Financial Group founder Matt McCall on the outlook for Trinity Industries.

  3. UK Trade Minister talks taxes

    UK Min. of State for Trade & Investment Lord Ian Livingston on the country’s plan to attract U.S. and foreign business.

  4. Treasury takes aim at corporate inversion

    FBN’s Liz MacDonald on deal stocks under pressure as the U.S. announces stricter tax rules.

  5. Political implications of the AbbVie-Shire deal

    Chapwood Investments’ Ed Butowsky and The Wall Street Journal Editorial Board’s Mary Kissel discuss the significance of AbbVie’s purchase of Ireland’s Shire.

  6. Abbott Laboratories 2Q earnings beat expectations

    Earnings HQ: FBN’s Adam Shapiro breaks down U.S. Bancorp’s second-quarter earnings report.

  7. Stocks to watch: CVS, ABT

    Kanaly Trust Chairman Drew Kanaly, Royal Oak Financial Group Managing Partner Matt Jehn and SFG Alternatives CIO Larry Shover on the opportunities in the markets for investors.

  8. Stocks to watch: KMI, ABT

    Glenmede Director of Investment Strategy Jason Pride, Wall Financial Group’s Michael Wall and OptionPit.com founder Mark Sebastian on where the opportunities are for investors.

  9. Stocks to watch: GOOGL, DOW

    Rosenthal Wealth Management Group President Larry Rosenthal, Platinum Partners President Uri Landesman and Tethys Partners Chief Market Strategist Bob Iaccino on the markets.

  10. Sell in May and go away?

    BlackRock chief investment strategist Russ Koesterich and Bianco Research president Jim Bianco on the state of the markets.

  11. Where should investors put their money to work?

    STA Wealth Management Chief Strategist Lance Roberts, USAA Investments V.P. John Toohey and Athena Advisor Services’ Dan Stecich on the outlook for the markets.

  12. Abbott Laboratories 1Q earnings

    Earnings HQ: FBN’s Jo Ling Kent breaks down Abbott Laboratories ’ first-quarter earnings report.

  1. Delta updates its SkyMiles program

    Travel expert Lee Abbamonte on the changes to Delta’s frequent flyer program and the truth about airline seat maps used when passengers book flights.

  2. Opportunities for investors in retail?

    Sassy Options founder Rachel Shasha, Glenmede Director of Investment Strategy Jason Pride and SFG Alternatives CIO Larry Shover on the outlook for stocks.

  3. Have oil prices bottomed out?

    LPL Financial Senior V.P. John Canally, Royal Oak Financial Group Managing Partner Matt Jehn and OptionPit.com founder Mark Sebastian on the outlook for stocks and oil.

  4. Bonds better for your portfolio?

    Stifel Nicolaus Portfolio Manager Chad Morganlander discusses the bond and stock markets, earnings, the economy and the 10-year Treasury.

  5. Abbott Laboratories posts mixed 4Q results

    Earnings HQ: FBN’s Ashley Webster breaks down Abbott Laboratories ’ fourth-quarter earnings report.

  6. Will the markets end the year flat despite the volatility?

    Glenmede Director of Investment Strategy Jason Pride, iSectors CIO Chuck Self and OptionPit.com founder Mark Sebastian on the outlook for the markets.

  7. Mylan CEO on generic drug industry, the FDA

    Mylan CEO Heather Bresch discusses the company’s impact on the health care industry, its deal with Abbott Laboratories , future developments and the FDA.

‹ Prev12345Next ›
Freebase CC-BY
Source: Abbott Laboratories on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL